Harvey-Bradshaw Index (HBI) for Crohn Disease
Simple clinical index for assessing Crohn disease activity. Simplified version of the Crohn Disease Activity Index (CDAI), not requiring a diary. Scores ≥5 indicate active disease.
Score interpretation
→ HBI 0–4: Clinical remission. Continue maintenance therapy; monitor CRP and faecal calprotectin. Annual review if stable; colonoscopic mucosal healing assessment as per guidelines.
→ HBI 5–7: Mild Crohn disease activity. Review adherence to maintenance therapy; consider step-up: budesonide or 5-ASA for colonic Crohn; check CRP and calprotectin; gastroenterology review.
→ HBI 8–16: Moderate Crohn disease activity. Systemic steroids (prednisolone 40 mg tapering); consider biologic escalation (anti-TNF/anti-integrin); surgical review if complications.
→ HBI >16: Severe Crohn disease activity. Hospital admission; IV hydrocortisone; nil by mouth if obstruction/perforation suspected; urgent IBD team and surgical review; CT abdomen.
Interpretation bands for the Harvey-Bradshaw Index. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Harvey-Bradshaw Index for Crohn's Disease · Inflammatory Bowel Disease
- Mayo Score for Ulcerative Colitis Activity · Inflammatory Bowel Disease
- Crohn's Disease Activity Index (CDAI) · Inflammatory Bowel Disease
- Truelove and Witts Severity Index for Ulcerative Colitis · Inflammatory Bowel Disease
- Ulcerative Colitis Endoscopic Index of Severity (UCEIS) · Inflammatory Bowel Disease
- Simplified Endoscopic Score for Crohn's Disease (SES-CD) · Inflammatory Bowel Disease
- Pindolol · Non-selective β-blocker (with intrinsic sympathomimetic activity)
- Dapsone · Anti-inflammatory / Antimicrobial
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Risankizumab · IL-23 Inhibitor — Psoriasis / Crohn's
- Colchicine · Anti-inflammatory — Neutrophilic Dermatoses / Vasculitis
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.